And the new drug known as "Linzess", and contains the active substance "linaclotide", which is available in capsule form obtained by the patient once a day on an empty stomach of food, and by at least half an hour of first appointment meal.
And helps drug "Linzess" on treatment of chronic constipation, which affects more than 63 million people around the world, in addition to 13 million patients suffering from irritable bowel syndrome irritable, helps the intestine and colon movement and increases the rate of Anaqbadtha, and also relieves abdominal pain and bowel that haunt patients a lot.
Have been confirmed as efficiently and safely this property by conducting two clinical trials on 1272 patients, and continued the study for 12 weeks, and the results showed significant positive, as improved mobility for patients and bowel painful symptoms disappeared to a large extent.
And warned the American people aged 17 years or less from the use of this property, and this warning came in the form of a black box is printed on the bulletin medication, diarrhea is one of the most prominent side effects associated with this property and complained of a large number of patients.